Informatie:
Fout:
ID
39196
Beschrijving
A Study to Evaluate the Safety and Pharmacokinetics After Oral Concurrent Administration of Fimasartan and Hydrochlorothiazide in Healthy Male Volunteers; ODM derived from: https://clinicaltrials.gov/show/NCT00923533
Link
https://clinicaltrials.gov/show/NCT00923533
Trefwoorden
Versies (1)
- 09-12-19 09-12-19 -
Houder van rechten
See clinicaltrials.gov
Geüploaded op
9 december 2019
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Essential Hypertension NCT00923533
Eligibility Essential Hypertension NCT00923533
- StudyEvent: Eligibility
Similar models
Eligibility Essential Hypertension NCT00923533
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Age
Item
age: 20 - 45 years
boolean
C0001779 (UMLS CUI [1])
Gender
Item
sex: male
boolean
C0079399 (UMLS CUI [1])
Body Weight
Item
body weight: greater than 55 kg
boolean
C0005910 (UMLS CUI [1])
Informed Consent
Item
written informed consent
boolean
C0021430 (UMLS CUI [1])
Hypersensitivity Fimasartan | Hydrochlorothiazide allergy
Item
known allergy to fimasartan and hydrochlorothiazide
boolean
C0020517 (UMLS CUI [1,1])
C2825622 (UMLS CUI [1,2])
C0571898 (UMLS CUI [2])
C2825622 (UMLS CUI [1,2])
C0571898 (UMLS CUI [2])
Heart Disease | Hematological Disease
Item
existing cardiac or hematological diseases
boolean
C0018799 (UMLS CUI [1])
C0018939 (UMLS CUI [2])
C0018939 (UMLS CUI [2])
Liver diseases | Kidney Diseases
Item
existing hepatic and renal diseases
boolean
C0023895 (UMLS CUI [1])
C0022658 (UMLS CUI [2])
C0022658 (UMLS CUI [2])
Gastrointestinal Diseases
Item
existing gastrointestinal diseases
boolean
C0017178 (UMLS CUI [1])
Disease Affecting Drug absorption | Disease Affecting Drug metabolism | Chronic disease Affecting Drug absorption | Chronic disease Affecting Drug metabolism
Item
acute or chronic diseases which could affect drug absorption or metabolism
boolean
C0012634 (UMLS CUI [1,1])
C0392760 (UMLS CUI [1,2])
C0678745 (UMLS CUI [1,3])
C0012634 (UMLS CUI [2,1])
C0392760 (UMLS CUI [2,2])
C0683140 (UMLS CUI [2,3])
C0008679 (UMLS CUI [3,1])
C0392760 (UMLS CUI [3,2])
C0678745 (UMLS CUI [3,3])
C0008679 (UMLS CUI [4,1])
C0392760 (UMLS CUI [4,2])
C0683140 (UMLS CUI [4,3])
C0392760 (UMLS CUI [1,2])
C0678745 (UMLS CUI [1,3])
C0012634 (UMLS CUI [2,1])
C0392760 (UMLS CUI [2,2])
C0683140 (UMLS CUI [2,3])
C0008679 (UMLS CUI [3,1])
C0392760 (UMLS CUI [3,2])
C0678745 (UMLS CUI [3,3])
C0008679 (UMLS CUI [4,1])
C0392760 (UMLS CUI [4,2])
C0683140 (UMLS CUI [4,3])
Serious mental illness
Item
history of any serious psychological disorder
boolean
C3841614 (UMLS CUI [1])
Drug screen positive | Alcohol consumption screening Positive
Item
positive drug or alcohol screening
boolean
C0743295 (UMLS CUI [1])
C0420032 (UMLS CUI [2,1])
C1514241 (UMLS CUI [2,2])
C0420032 (UMLS CUI [2,1])
C1514241 (UMLS CUI [2,2])
Tobacco use Number of cigarettes per day
Item
smokers of 10 or more cigarettes per day 3 month ago
boolean
C0543414 (UMLS CUI [1,1])
C3694146 (UMLS CUI [1,2])
C3694146 (UMLS CUI [1,2])
Study Subject Participation Status | Clinical Trial
Item
participation in a clinical trial during the last 2 months prior to the start of the study
boolean
C2348568 (UMLS CUI [1])
C0008976 (UMLS CUI [2])
C0008976 (UMLS CUI [2])